A phase II study of bisantrene in malignant lymphomas. A Southwest Oncology Group Study.

MLA

Miller, Thomas, et al. “A Phase II Study of Bisantrene in Malignant Lymphomas. A Southwest Oncology Group Study.” Cancer Chemotherapy & Pharmacology, vol. 16, no. 1, Jan. 1986, pp. 67–69. EBSCOhost, https://doi.org/10.1007/BF00255289.

APA

Miller, T., Cowan, J., Neilan, B., Jones, S., Miller, T. P., Cowan, J. D., Neilan, B. A., & Jones, S. E. (1986). A phase II study of bisantrene in malignant lymphomas. A Southwest Oncology Group Study. Cancer Chemotherapy & Pharmacology, 16(1), 67–69. https://doi.org/10.1007/BF00255289

Chicago

Miller, Thomas, John Cowan, Barbara Neilan, Stephen Jones, T P Miller, J D Cowan, B A Neilan, and S E Jones. 1986. “A Phase II Study of Bisantrene in Malignant Lymphomas. A Southwest Oncology Group Study.” Cancer Chemotherapy & Pharmacology 16 (1): 67–69. doi:10.1007/BF00255289.